A reduction in PTEN dosage by BART1 activated PTEN-dependent pathways, induced EMT, and boosted nasopharyngeal cancer migration, invasion, and metastasis [12]. The gene discussed is ARL2BP; the disease is nasopharyngeal carcinoma.